Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 6/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.54 |
| ▸ | ATM | Q13315 | 4/20 | 0.54 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.50 |
| ▸ | PDE5A | O76074 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5805189 | 0.89 | MAPT (0.64) | MAPTALDH1A1SMN1; SMN2HTTMEN1 | |
| SCHEMBL5693269 | 0.83 | MAPT (0.59) | MAPTALDH1A1SMN1; SMN2HTTMEN1 | |
| SCHEMBL22796281 | 0.80 | ESD (0.53) | MAPTALDH1A1SMN1; SMN2HTTKMT2A | |
| SCHEMBL5052866 | 0.80 | MAPT (0.55) | MAPTALDH1A1SMN1; SMN2HTTMEN1 | |
| SCHEMBL13387492 | 0.79 | MAPT (0.47) | MAPTALDH1A1SMN1; SMN2HTTMEN1 | |
| SCHEMBL17012695 | 0.79 | MAOB (0.64) | MAPTALDH1A1SMN1; SMN2HTTKMT2A | |
| SCHEMBL5802366 | 0.79 | MAPT (0.57) | MAPTALDH1A1SMN1; SMN2HTTMEN1 | |
| SCHEMBL11068412 | 0.78 | MEN1 (0.54) | MAPTALDH1A1SMN1; SMN2HTTMEN1 | |
| SCHEMBL31537146 | 0.78 | MAPT (0.46) | MAPTALDH1A1SMN1; SMN2HTTMEN1 | |
| SCHEMBL11208392 | 0.77 | EGFR (0.74) | MAPTALDH1A1HTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119698496-A | Electrochemical synthesis of pyrazolines and pyrazoles | 拜耳公司 | 2025-03-25 | — | — | CN | disclosed |
| US-20200390100-A1 | SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AG (DE) | 2020-12-17 | — | — | US | disclosed |
| EP-2592086-A1 | TELOMERASE INHIBITORS AND A METHOD FOR THE PREPARATION THEREOF | Gosudarstvennoe Uchebno-nauchnoe Uchrezhdenie Khimichesky Fakultet MGU Im. M.V. Lomonosova (RU) | 2013-05-15 | — | — | EP | disclosed |
| EP-0357454-B1 | Electrophotographic process | XEROX CORP (US) | 2000-12-27 | — | — | EP | disclosed |
| US-6156466-A | Photoconductor for electrophotography | FUJI ELECTRIC CO., LTD. (JP) | 2000-12-05 | — | — | US | disclosed |
| US-5595851-A | Conductive developer compositions with coated carrier particles | XEROX CORPORATION (US) | 1997-01-21 | — | — | US | disclosed |
| EP-0276147-B1 | Toner and developer compositions with long chain alcohol waxes | XEROX CORP (US) | 1996-12-27 | — | — | EP | disclosed |
| EP-0278785-B1 | Liquid developer compositions with high transfer efficiency | XEROX CORP (US) | 1996-05-29 | — | — | EP | disclosed |
| US-5322752-A | Development process for abrasion resistant documents | XEROX CORPORATION (US) | 1994-06-21 | — | — | US | disclosed |
| US-5304450-A | Processes for the preparation of toner compositions | XEROX CORPORATION (US) | 1994-04-19 | — | — | US | disclosed |
| US-4073965-A | SULFONAMIDO PHTHALOCYANINE TONER RESINS | XEROX CORPORATION (US) | 1978-02-14 | — | — | US | disclosed |
| US-4066563-A | COPPER-TETRA-4-(OCTADECYLSULFONOMIDO) PHTHALOCYANINE ELECTROPHOTOGRAPHIC CARRIER | XEROX CORPORATION (US) | 1978-01-03 | — | — | US | disclosed |
| US-4063946-A | Electrophotographic color reproduction process employing photoconductive material with dual light fatigue properties | RANK XEROX LTD. (EN) | 1977-12-20 | — | — | US | disclosed |
| US-4058397-A | ELECTROGRAPHY, DISAZO DYE, COPPER TETRA-4-(OCTADECYL SULFONAMIDO) PHTHALOCYANINE | XEROX CORPORATION (US) | 1977-11-15 | — | — | US | disclosed |
| US-4057426-A | ELECTROSTATIC, 2,9-DIMETHYL-QUINACRIDONE, COPPER TETRA-4-(OCTADECYLSULFONAMIDO) PHTHALOCYANINE | XEROX CORPORATION (US) | 1977-11-08 | — | — | US | disclosed |
| US-4043929-A | Electrostatographic carrier composition | XEROX CORPORATION (US) | 1977-08-23 | — | — | US | disclosed |
| US-4019842-A | Apparatus for forming magnetite electrostatographic carriers | XEROX CORPORATION (US) | 1977-04-26 | — | — | US | disclosed |
| US-3989860-A | Repair technique for photoreceptors | XEROX CORPORATION (US) | 1976-11-02 | — | — | US | disclosed |
| US-3963486-A | Electrophotographic imaging process employing epoxy-ester containing liquid developer | RANK XEROX LTD. (EN) | 1976-06-15 | — | — | US | disclosed |
| US-3955977-A | GRAPHIC DISPLAYS | XEROX CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200390100-A1 | SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES | DDT, NOTUM, AGPS | MAPT 3730/4885ALDH1A1 201/4885SMN1; SMN2 4626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.